Tenon Medical

Tenon Medical AAQS

The The AAQS of Tenon Medical (TNON) as of Oct 21, 2026 is 3. In the previous year, The AAQS was 3.00 — a change of 0.00% (lower).

AAQS

3

YoY

0.00%

Last updated:

Tenon Medical has a current AAQS of 3.

A high AAQS can be seen as a positive indicator that the company is developing successfully.

Investors can assume that the company is on a good path to generate profits.

On the other hand, it is important to consider the AAQS of the stock Tenon Medical in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.

In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.

The Tenon Medical AAQS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

AAQS
Date
AAQS
Jan 1, 2019
3.00 USD
Jan 1, 2020
3.00 USD
Jan 1, 2021
3.00 USD
Jan 1, 2022
3.00 USD
Jan 1, 2023
3.00 USD
Jan 1, 2024
3.00 USD
Jan 1, 2025
3.00 USD
The Tenon Medical AAQS history
YEARAAQSYoY
30.00%
30.00%
30.00%
30.00%
30.00%
30.00%
3—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Tenon Medical Stock analysis

What does Tenon Medical do? Tenon Medical Inc generates revenue through the sale of its Catamaran SI Joint Fusion System, a medical device designed to treat sacroiliac joint disorders causing lower back pain. The system includes the Catamaran Fixation Device, which stabilizes the SI Joint by transfixing it along its longitudinal axis using a single titanium implant. The company targets orthopedic surgeons and hospitals specializing in spinal and joint treatments, with the Catamaran System marketed as a solution for the most common SI Joint disorders. Tenon Technology AG serves as the company's subsidiary, supporting the development and commercialization of the medical device technology. The Catamaran System is positioned as a specialized surgical solution, featuring a unique approach that avoids critical neural and vascular structures while targeting strong cortical bone. The company's focus on the sacroiliac joint market differentiates it from broader orthopedic device manufacturers, with the product designed to address specific patient needs in lower back pain management. Revenue streams are derived from direct sales of the system to healthcare providers and hospitals, leveraging the proprietary surgical technique and implant design. Tenon Medical Inc. operates within the Health Care Equipment & Supplies industry, with its primary product being the Catamaran SI Joint Fusion System. The company's business model centers on developing and selling medical devices that provide targeted treatment for SI Joint disorders, using a single titanium implant that transfixes the joint. The subsidiary Tenon Technology AG plays a role in supporting the company's technological advancements and market positioning. Tenon Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Tenon Medical stock

The AAQS of Tenon Medical is 3 in 2025.

On Eulerpool you can find the complete historical development of The AAQS Tenon Medical since 2006 – with annual values, charts, and detailed analysis.

The AAQS is a key figure developed by AlleAktien.

The AAQS is a key figure developed by AlleAktien.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Tenon Medical

All Key Metrics — Tenon Medical